Injectable Drugs for Diabetes Part 2 PDF
Document Details
Uploaded by leichnam
Emory & Henry College
Tags
Summary
This document contains questions and answers about different types of insulin and their uses in managing diabetes. It covers various aspects, such as the characteristics of short-acting and long-acting insulins, common concentrations, and typical administration times. This study guide is for medical professionals or students.
Full Transcript
\#\#\# \*\*Slide 11: Types of Insulin\*\* 1\. \*\*What characteristic distinguishes short-acting insulin from long-acting insulin?\*\* \- A. Onset of action \- B. Route of administration \- C. Side effect profile \- D. Cost \*\*Answer:\*\* A. Onset of action 2\. \*\*Which insulin concentratio...
\#\#\# \*\*Slide 11: Types of Insulin\*\* 1\. \*\*What characteristic distinguishes short-acting insulin from long-acting insulin?\*\* \- A. Onset of action \- B. Route of administration \- C. Side effect profile \- D. Cost \*\*Answer:\*\* A. Onset of action 2\. \*\*Which insulin concentration is the most commonly used?\*\* \- A. U-100 \- B. U-200 \- C. U-300 \- D. U-500 \*\*Answer:\*\* A. U-100 3\. \*\*Which of the following insulins would be used to control fasting blood glucose levels?\*\* \- A. Regular insulin \- B. Rapid-acting insulin \- C. Long-acting insulin \- D. Inhaled insulin \*\*Answer:\*\* C. Long-acting insulin \-\-- \#\#\# \*\*Slide 12: Endogenous Insulin Production\*\* 1\. \*\*At what blood glucose level does the pancreas begin to release insulin?\*\* \- A. 80 mg/dL \- B. 100 mg/dL \- C. 140 mg/dL \- D. 180 mg/dL \*\*Answer:\*\* C. 140 mg/dL 2\. \*\*How long after a meal does insulin secretion begin in response to increased blood glucose?\*\* \- A. 10 seconds \- B. 30 seconds \- C. 90 seconds \- D. 2 minutes \*\*Answer:\*\* C. 90 seconds 3\. \*\*Which of the following most accurately describes insulin production?\*\* \- A. Insulin production is constant and independent of meals \- B. Insulin is produced only in response to fasting \- C. Insulin is produced based on food intake and blood glucose levels \- D. Insulin production occurs only during physical activity \*\*Answer:\*\* C. Insulin is produced based on food intake and blood glucose levels \-\-- \#\#\# \*\*Slide 13: Common Types of Insulin\*\* 1\. \*\*Which of the following is an example of a rapid-acting insulin?\*\* \- A. Humulin R \- B. Lantus \- C. Humalog \- D. Tresiba \*\*Answer:\*\* C. Humalog 2\. \*\*Which type of insulin is typically used at mealtimes to control postprandial glucose levels?\*\* \- A. Short-acting insulin \- B. Rapid-acting insulin \- C. Intermediate-acting insulin \- D. Long-acting insulin \*\*Answer:\*\* B. Rapid-acting insulin 3\. \*\*Which type of insulin is categorized as \"basal\" insulin?\*\* \- A. Intermediate-acting insulin \- B. Rapid-acting insulin \- C. Long-acting insulin \- D. Short-acting insulin \*\*Answer:\*\* C. Long-acting insulin \-\-- \#\#\# \*\*Slide 16: Rapid-Acting Insulin\*\* 1\. \*\*Which of the following insulins has the fastest onset of action?\*\* \- A. Apidra \- B. Humulin N \- C. Lantus \- D. Tresiba \*\*Answer:\*\* A. Apidra 2\. \*\*Rapid-acting insulin should be injected at which of the following times?\*\* \- A. 30 minutes before a meal \- B. 15 minutes before a meal \- C. 1 hour after a meal \- D. At bedtime only \*\*Answer:\*\* B. 15 minutes before a meal 3\. \*\*What is the approximate duration of action for rapid-acting insulin like NovoLog?\*\* \- A. 1-3 hours \- B. 3-5 hours \- C. 5-8 hours \- D. 8-10 hours \*\*Answer:\*\* B. 3-5 hours \-\-- \#\#\# \*\*Slide 18: Short-Acting Insulin\*\* 1\. \*\*Which of the following insulins is a short-acting insulin?\*\* \- A. Humalog \- B. Humulin R \- C. Tresiba \- D. Lantus \*\*Answer:\*\* B. Humulin R 2\. \*\*Short-acting insulin, such as Regular insulin, has an onset of action within:\*\* \- A. 10-15 minutes \- B. 30-60 minutes \- C. 1-2 hours \- D. 2-3 hours \*\*Answer:\*\* B. 30-60 minutes 3\. \*\*In the hospital setting, Regular insulin is often administered intravenously to manage:\*\* \- A. Diabetic ketoacidosis (DKA) \- B. Hypoglycemia \- C. Hyperlipidemia \- D. Postoperative pain \*\*Answer:\*\* A. Diabetic ketoacidosis (DKA) \-\-- \#\#\# \*\*Slide 19: Intermediate-Acting Insulin (NPH)\*\* 1\. \*\*Which insulin is classified as intermediate-acting?\*\* \- A. Humulin N \- B. Lantus \- C. Apidra \- D. Tresiba \*\*Answer:\*\* A. Humulin N 2\. \*\*How should NPH insulin be handled before injection?\*\* \- A. Shake vigorously \- B. Leave undisturbed for 10 minutes \- C. Gently roll the vial to distribute the suspension \- D. Inject immediately without any preparation \*\*Answer:\*\* C. Gently roll the vial to distribute the suspension 3\. \*\*Intermediate-acting insulin, like NPH, typically reaches its peak effect within:\*\* \- A. 1-2 hours \- B. 4-10 hours \- C. 12-16 hours \- D. 24-36 hours \*\*Answer:\*\* B. 4-10 hours \-\-- \#\#\# \*\*Slide 21: Long-Acting Insulin\*\* 1\. \*\*Which long-acting insulin is considered \"peakless\" and mimics basal insulin production?\*\* \- A. Lantus \- B. Humulin N \- C. Apidra \- D. NovoLog \*\*Answer:\*\* A. Lantus 2\. \*\*Which long-acting insulin has the longest duration of action, lasting up to 42 hours?\*\* \- A. Lantus \- B. Tresiba \- C. Levemir \- D. Humalog \*\*Answer:\*\* B. Tresiba 3\. \*\*Why should long-acting insulins, such as Lantus or Tresiba, not be mixed with other insulins in the same syringe?\*\* \- A. They will become too potent \- B. Mixing them with other insulins inactivates the long-acting insulin \- C. They cause an immediate release of insulin \- D. There is a risk of overdose \*\*Answer:\*\* B. Mixing them with other insulins inactivates the long-acting insulin \-\-- \#\#\# \*\*Slide 20: NPH Insulin (Additional)\*\* 1\. \*\*Which insulin has a milky appearance and requires rolling before injection?\*\* \- A. NPH insulin \- B. Rapid-acting insulin \- C. Long-acting insulin \- D. Regular insulin \*\*Answer:\*\* A. NPH insulin 2\. \*\*How often is NPH insulin typically administered?\*\* \- A. Once daily \- B. Twice daily \- C. After every meal \- D. Once weekly \*\*Answer:\*\* B. Twice daily 3\. \*\*Which of the following is a common complication with the use of NPH insulin?\*\* \- A. Hypoglycemia \- B. Hyperglycemia \- C. Weight loss \- D. Insulin resistance \*\*Answer:\*\* A. Hypoglycemia \#\#\# \*\*Slide 17: Rapid-Acting Insulin - Vial & Pen Forms\*\* 1\. \*\*Which of the following is an example of a rapid-acting insulin?\*\* \- A. Apidra (insulin glulisine) \- B. Humulin N \- C. Lantus \- D. Tresiba \*\*Answer:\*\* A. Apidra (insulin glulisine) 2\. \*\*What is the typical onset of action for rapid-acting insulins such as Humalog or NovoLog?\*\* \- A. 10-30 minutes \- B. 30-60 minutes \- C. 1-2 hours \- D. 3-5 hours \*\*Answer:\*\* A. 10-30 minutes 3\. \*\*How long does rapid-acting insulin typically last in the body?\*\* \- A. 1-2 hours \- B. 3-5 hours \- C. 5-8 hours \- D. 12-24 hours \*\*Answer:\*\* B. 3-5 hours 4\. \*\*When should rapid-acting insulin be administered in relation to meals?\*\* \- A. 30 minutes before meals \- B. 15 minutes before meals or immediately after \- C. 1 hour after meals \- D. Only at bedtime \*\*Answer:\*\* B. 15 minutes before meals or immediately after 5\. \*\*Rapid-acting insulin is most commonly used in which of the following therapeutic settings?\*\* \- A. Basal insulin therapy \- B. Postprandial glucose control \- C. Fasting glucose control \- D. Management of insulin resistance \*\*Answer:\*\* B. Postprandial glucose control 6\. \*\*In which forms can rapid-acting insulin be administered?\*\* \- A. Subcutaneous (via insulin pump) and intravenous (IV) infusion \- B. Subcutaneous injection only \- C. Intramuscular injection only \- D. Oral tablets and subcutaneous injection \*\*Answer:\*\* A. Subcutaneous (via insulin pump) and intravenous (IV) infusion 7\. \*\*Which of the following rapid-acting insulins is available in both vial and pen forms?\*\* \- A. Apidra (insulin glulisine) \- B. NPH insulin \- C. Levemir \- D. Tresiba \*\*Answer:\*\* A. Apidra (insulin glulisine) 8\. \*\*Why is it important to eat soon after injecting rapid-acting insulin?\*\* \- A. To avoid hyperglycemia \- B. To prevent hypoglycemia \- C. To increase the insulin\'s duration of action \- D. To improve insulin absorption \*\*Answer:\*\* B. To prevent hypoglycemia